Skip to main content

Table 1 Demographic, clinical, and biochemical characteristics of the patients

From: Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study

Parameter

Values

N

37

Age (years)

55.2 ± 12.9

Female (n, %)

36 (97.3%)

Disease duration (years)

9 (0.5–42)

Skin ulcers (n, %)

12 (32.4%)

ESR (mm/h)

22.6 ± 18

Total cholesterol (mg/dL)

195 ± 41

Creatinine (mg/dL)

0.79 ± 0.25

ANA + (n, %)

33 (89.1%)

Anti-Scl-70 + (n, %)

13 (35.1%)

ACA + (n, %)

16 (43.2)

Type of the disease (n, %)

 Diffuse

13 (35.2%)

 Limited

24 (64.8%)

PAH

8 (21.6%)

Interstitial lung fibrosis (n, %)

14 (37.8%)

NVC patterns (n, %)

 Early

11 (29.7%)

 Active

10 (27.0%)

 Late

16 (43.2%)

CSURI

4.2 (0.63–34.6)

cIMT (mm)

 Right

0.74 ± 0.14

 Left

0.68 (0.52–1.16)

PWV (m/s)

7.2 (4.8–18.5)

AIx (%)

30.2 ± 11.6

CSBP (mmHg)

121 ± 20

SBP (mmHg)

131 ± 21

DBP (mmHg)

76 ± 10

Calcium channel blockers (n, %)

19 (51.4)

Vasodilators

 ERAs (n, %)

10 (27%)

 PDEi (n, %)

2 (5.4%)

  1. ESR erythrocyte sedimentation rate, PAH pulmonary arterial hypertension, CSURI capillaroscopic skin ulcer risk index, cIMT carotid intima-media thickness, PWV pulse wave velocity, AIx augmentation index, CSBP central systolic blood pressure, SBP systolic blood pressure, DBP diastolic blood pressure, ERAs endothelin receptor antagonists, PDEi phosphodiesterase inhibitors
  2. Normally distributed continuous variables are expressed as mean ± standard deviation, whereas those not normally distributed are expressed as median (range)